Monoclonal Antibodies and Antibody-Drug Conjugates: Expanding the Therapeutic Arsenal in Multiple Myeloma. (PubMed, Cancer J) - Sep 30, 2026 - "Furthermore, challenges in the sequencing of treatments have emerged, as novel immunotherapies have also become available in the early relapse setting. This contemporary review examines the evolving role of mAbs and ADCs in MM, addressing both current status and directions for future research in the field."
Journal • Review • Hematological Malignancies • Multiple Myeloma • Oncology
|
|
Evangelos Terpos; Ioannis Ntanasis-Stathopoulos; Meletios-Athanasios Dimopoulos
|